CryoLife (AORT) Price to Earnings Ratio

Corporate emblem and logo of CryoLife (AORT)

Stable demand for cardiac implants provides Artivion, Inc. (AORT) with a predictable cash flow. The company's historical P/E range demonstrates the market valuation of this resilience, where -50.20 captures the current state of the parameter. The business relies on surgeon loyalty and stringent FDA barriers, complementing this with rigorous internal quality control when procuring raw materials from external counterparties.

Artivion Corp (AORT) Price to Earnings Ratio: for the period 07/04/2022 - 11/17/2026
Original product of artivion.com

The P/E ratio determines the market value of a business relative to its net income, allowing an investor to assess the investment payback period and the asset's level of overboughtness. By analyzing the P/E chart for Artivion, Inc. (AORT), one can compare market expectations with the high margins of Artivion, Inc. (AORT), where stable demand for cardiovascular implants ensures predictable cash flows and the fundamental stability of the share price.

Analysis of competing companies

Price to Earnings Ratio BSX|Price to Earnings Ratio EW (Edwards Lifesciences Corporation)|Business Payback Period ResMed Inc.|P/E Multiple PODD (insulet.com)|ZBH (Zimmer Biomet Holdings, Inc.) - Market Cap to Net Income|CooperSurgical - P/E Multiple|Market Cap to Net Income ALGN|GMED: P/E Multiple|Market Cap to Earnings TransMedics Group (TMDX)|ATEC (Alphatec) - P/E Multiple|Price to Earnings Multiple ENOV (Enovis)|Price to Earnings Ratio IART (Integra LifeSciences Holdings Corporation)|ESTA (Establishment Labs Corp) - Company Value to Net Income|Price to Earnings Ratio iLet Bionic Pancreas BBNX|IRMD - Price to Earnings Ratio|Embecta Corp - P/E Multiple|Market Cap to Earnings Tandem Diabetes Care|AXGN: P/E Multiple|Price to Earnings Multiple SIBN|OFIX (Orthofix Corp) - P/E Multiple|Price to Earnings Ratio Bioventus Corp (BVS)|P/E Multiple KIDS|Price to Earnings Ratio Treace Medical Concepts TMCI|P/E Multiple SRTA (blade.com)|P/E Multiple Carlsmed, Inc. CARL|RXST - Price to Earnings Ratio|CLPT: Price to Earnings Ratio|STXS (Stereotaxis, Inc.) - Price to Earnings Ratio|Neuronetics, Inc. - Company Value to Net Income|SGHT (Sight Sciences Inc) - P/E Multiple|Market Cap to Earnings Orchestra BioMed Inc. OBIO|Price to Earnings Ratio Anika Therapeutics, Inc. (ANIK)|InspireMD, Inc. (NSPR) - Market Cap to Net Income Ratio|Jin Medical International Ltd. - Price to Earnings Ratio|P/E Multiple Vivani VANI|Xtant Medical Holdings, Inc. - P/E Multiple|Business Payback Period NeuroOne NMTC|Modular Medical, Inc. (MODD) - Price to Earnings Ratio|Price to Earnings Ratio Myomo, Inc|Price to Earnings Ratio envoymedical.com|Price to Earnings Ratio Vivos Therapeutics (VVOS)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical, Inc. TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|Business Payback Period invobioscience.com IVF|BBLG: P/E Multiple|Axonics Modulation Technologies (AXNX) - P/E Multiple|BIOL (Biolase Inc.) - P/E Multiple|Market Cap to Earnings dynatronics.com DYNT|P/E Multiple FNA|Price to Earnings Ratio INVO (INVO Bioscience Inc.)